Net profit of Concord Biotech rose 11.12% to Rs 70.65 crore in the quarter ended September 2026 as against Rs 63.58 crore during the previous quarter ended September 2025. Sales rose 25.10% to Rs 309.07 crore in the quarter ended September 2026 as against Rs 247.06 crore during the previous quarter ended September 2025.